Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Lung Ultrasound Identifies Patients with Coronavirus

By HospiMedica International staff writers
Posted on 06 Apr 2020
A new study outlines four brief acquisition protocols for performing lung ultrasonography on patients with COVID-19. More...


The protocols, developed at the University of Pavia (Italy), Valle del Serchio General Hospital (Lucca, Italy), the University of Trento (Italy), and other institutions outline the best probe to use, where clinicians should look for artifacts, where to set the focus, and how to visualize the widest surface possible with one scan. The protocols are based on finding that COVID-19 patients develop thickened pleura, B-lines, subpleural consolidations, and other hallmark lung ultrasound artifacts.

The four acquisition protocols include the following recommendations:
• Use of linear probes, as these can best capture the detail of pleural and subpleural artifacts; convex probes are also appropriate.
• Using a single focal point modality at the pleural line, instead of focusing at multiple locations.
• Scans should preferably be performed in intercostal spaces, as opposed to an orthogonal view of the ribs. This enables clinicians to see the widest surface possible with one scan.
• Artifacts should be looked for in multiple areas and bilaterally to see the extent of the affected lung surface, specifically in the apical, medial, and basal sections of the anterior midclavicular and posterior paraspinal sections, and in the apical and basal lateral axillary areas.

The study was published on March 20, 2020, in the Journal of Ultrasound in Medicine.

“Lung ultrasound can be used for triaging patients before hospital admission, monitoring emergency department patients with pneumonia, managing ventilation and weaning for intensive care unit patients, and evaluating the effects of antiviral medications,” concluded lead author Gino Soldati MD, of the ultrasound unit at Valle del Serchio General Hospital, and colleagues. “This is because ultrasound can identify changes in the ratio between air, tissue, and fluid in the lungs of patients with COVID-19.”

While CT has excellent ability to detect COVID-19, the modality can't be used at patients' bedsides and it puts additional medical staff at risk for virus exposure. As a result, some doctors in China, Spain, and Italy have turned to lung ultrasound as an alternative imaging modality.

Related Links:
University of Pavia
University of Trento



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Electrode Solution and Skin Prep
Signaspray
Gold Member
UGPIV Barrier and Securement
UltraDrape II
Medical Monitor
VITALMAX 4100SL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.